Medicamen Biotech Chart
Medicamen Biotech Share Key Metrics
Volume
20491.00
Market Cap
349.46 CR
LTQ@LTP
89@257.66
ATP
258.03
Var Margin
22.31 %
Circuit Range
207.59-311.37
Delivery %
63.33 %
Value
52.87 L
ASM/GSM
No
Market Lot
1
Summary
Medicamen Biotech Fundamentals
View MoreP/E Ratio
37.01
P/B Ratio
1.29
Div. Yield
0.39
Sector P/E
65.13
Sector P/B
3.53
Sec. Div. Yield
0.57
Medicamen Biotech Resistance and Support
Pivot 261.74
Resistance
First Resistance
266.18
Second Resistance
272.89
Third Resistance
277.33
Support
First Support
255.03
Second Support
250.59
Third Support
243.88
Medicamen Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-26 | Preferential issue of shares |
| 2025-02-11 | Quarterly Results |
Medicamen Biotech News
Medicamen Biotech Ltd-$ - 531146 - Announcement Under Regulation 30 (LODR) - Intimation Regarding Incorrect Event Disply On NSDL Portal
Medicamen Biotech clarified an incorrect event display on its NSDL portal, confirming that no such event was initiated or authorized by the company. The matter has been escalated to NSDL for necessary verification and rectification, with no material disclosure required from the company.
Apr 06 2026 16:04:00
About Medicamen Biotech
NSE : 6278
BSE : 531146
ISIN : INE646B01010
MBL was incorporated as a public limited company under the Companies Act 1956 on December 22 1993. The certificate of commencement of business was obtained on January 31 1994. The company has jointly been promoted by Mr.V.Kumar Mr.Bal Kishan Gupta Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst Cadila Hindustan Ciba Purepharma Oboi Labs etc. and exporting to countries like Germany Russia Holland CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.MBL has obtained permission for production of tablets capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited New Delhi and Pure Pharma Private Limited Indore respectively.
Medicamen Biotech Management
| Name | Position |
|---|---|
| Rahul Bishnoi | Chairman |
| Vimal Kumar Shrawat | Non Independent & Non Executive Director |
Medicamen Biotech FAQs
